CBS 2019
CBSMD教育中心
中 文

Cardio-Oncology

Abstract

Recommended Article

Cardiovascular Toxicity in Cancer Survivors: Current Guidelines and Future Directions Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1 Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis Exercise Therapy and Cardiovascular Toxicity in Cancer Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2 Lack of Association Between Heart Failure and Incident Cancer

Clinical Trial2018;4.Epub 2018 Aug 29.

JOURNAL:Cardiooncology. Article Link

Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers

Poklepovic A, Qu Y, Dickinson M et al. Keywords: Anthracycline; Biomarker; Cardioprotection; Chemotherapy; Clinical trial; Doxorubicin; Ejection fraction; Strain

FULL TEXT PDF